BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 4566104)

  • 21. Immunosuppressive therapy in rheumatic disease.
    Pirofsky B; Bardana EJ
    Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL; Shtutman VZ; Nasonova VA
    Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunosuppressive agents in rheumathology].
    Dorfmann H; Dreyfus P
    Cah Coll Med Hop Paris; 1969 Oct; 10(12):1014-6. PubMed ID: 5308521
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of the effects of phenylbutazone and a combination preparation (Exrheudon) in rheumatic diseases].
    Engel P
    MMW Munch Med Wochenschr; 1977 Jan; 119(3):93-4. PubMed ID: 403430
    [No Abstract]   [Full Text] [Related]  

  • 25. Update: treatment of rheumatic disease.
    Solomon SD
    J Med Soc N J; 1978 Nov; 75(12):855-8. PubMed ID: 361956
    [No Abstract]   [Full Text] [Related]  

  • 26. [Side effects of antibiotics in rheumatic diseases].
    Matveĭkov GP; Pshonik SS; Poliakova TI; Aronin TsS
    Antibiotiki; 1977 Sep; 22(9):813-6. PubMed ID: 20835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical experience with indomethacin].
    Feyen H; Hiemeyer V; Pötting H
    Med Klin; 1968 Oct; 63(40):1593-6. PubMed ID: 5305247
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical research with a new non-steroid drug, ibuprofen, in rheumatology].
    Marmont A; Rossi F; Bordo D
    Minerva Med; 1973; 64(48):2576-84. PubMed ID: 4580159
    [No Abstract]   [Full Text] [Related]  

  • 29. [Digestive tolerance of phenylbutazone with an alkaline coating. Initial therapeutic clinical study of 22 cases. Preliminary report].
    Carneiro RA
    Hospital (Rio J); 1969 Jun; 75(6):2123-30. PubMed ID: 5311469
    [No Abstract]   [Full Text] [Related]  

  • 30. Butazolidin suppository medication in rheumatism; a clinical study in general practice.
    McIntosh IB
    J Int Med Res; 1977; 5 Suppl 2():81-4. PubMed ID: 303188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of inflammatory rheumatic diseases using cytembena].
    Hándlová D; Vojtísek O; Králová M; Brémová A; Kanková D; Pavelka K
    Fysiatr Revmatol Vestn; 1972 Oct; 50(5):278-83. PubMed ID: 4538713
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment in rheumatology with a new injectable salt of indomethacin].
    Coari G; Taccari E
    Minerva Med; 1974 Mar; 65(17):917-22. PubMed ID: 4545238
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of articular and non-articular (rheumatic diseases by indomethacin suppositories).
    Vaishnava H; Dasgupta MK; Sachar MS
    J Assoc Physicians India; 1971 Feb; 19(2):157-65. PubMed ID: 4934419
    [No Abstract]   [Full Text] [Related]  

  • 34. A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).
    Rabasseda X
    Drugs Today (Barc); 2014 Dec; 50(12):829-41. PubMed ID: 25588087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Some new possibilities for the use of ketophenylbutazone (Ketazon-Spofa) in rheumatology].
    Rejholec V
    Reumatizam; 1966; 13(6):205-9. PubMed ID: 5973922
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ketoprofen in rheumatic arthropathies in old age. Double-blind studies].
    Ricciardi S; Filosa E
    Clin Ter; 1977 Dec; 83(6):593-608. PubMed ID: 343974
    [No Abstract]   [Full Text] [Related]  

  • 37. Analgesics and non-steroid anti-inflammatory agents in rheumatic disease.
    Hart FD
    Practitioner; 1972 Jan; 208(243):10-7. PubMed ID: 4536903
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy for childhood rheumatic diseases. Have we been doing enough?
    Schaller JG
    Arthritis Rheum; 1993 Jan; 36(1):65-70. PubMed ID: 8424838
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experiences with a new phenylbutazone preparation: Alka-Butazolidine].
    Porzio F; Tuzi T
    Rass Int Clin Ter; 1972 May; 52(10):583-90. PubMed ID: 4537829
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.
    Lignière GC; Colombo B; Carrabba M; Ferrari P; Robotti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:253-8. PubMed ID: 4553232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.